Highlights Intra-Cellular Therapies, Inc.

Equities

ITCI

US46116X1019

Real-time Estimate Cboe BZX Other stock markets 12:45:14 2024-05-21 pm EDT			5-day change	1st Jan Change
66.38 ^USD	+1.63%		+0.88%	-7.44%

May. 16	Transcript : Intra-Cellular Therapies, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 09:20 AM
May. 07	Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	May. 07	MT
Intra-Cellular Therapies' Q1 Net Loss Narrows, Net Total Revenue Rises	May. 07	MT
Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q1 Revenue $144.9M	May. 07	MT
Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q1 Revenue $144.9M	May. 07	MT
Intra-Cellular Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Intra-Cellular Therapies, Inc. Reiterates Earnings Guidance for the Full Year 2024	May. 07	CI
Intra-Cellular Therapies Prices $500 Million Stock Offering	Apr. 18	MT
Intra-Cellular Therapies Launches $500 Million Public Offering of Stock; Shares Edge Lower in Late Trade	Apr. 16	MT
Sector Update: Health Care Stocks Higher Late Afternoon	Apr. 16	MT
Top Midday Gainers	Apr. 16	MT
Intra-Cellular Therapies Stock Jumps After Major Depressive Disorder Treatment Study Shows Positive Results	Apr. 16	MT
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder	Apr. 16	CI
Intra-Cellular Therapies Q4 Loss Narrows, Revenue Increases	Feb. 22	MT
Intra-Cellular Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Reports Q4 Revenue $132.1M	Feb. 22	MT
Intra-Cellular Therapies, Inc. Provides Earnings Guidance for the Full Year 2024	Feb. 22	CI
Intra-Cellular Therapies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Reports Q3 Revenue $126.2M	Nov. 02	MT
Intra-Cellular Therapies, Inc. Provides Sales Guidance for the Fiscal Year 2023	Nov. 02	CI
Intra-Cellular Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Intra-Cellular Therapies, Inc.

Equities

ITCI

US46116X1019

Highlights

Filters